Search for author "Brian W. McCrindle"

• You have accessRestricted access

  The Optimal Timing of Stage-2-Palliation for Hypoplastic Left Heart Syndrome: An analysis of the Pediatric Heart Network Single Ventricle Reconstruction Trial Public Dataset

  James M. Meza, Edward J. Hickey, Eugene H. Blackstone, Robert D. B. Jaquiss, Brett R. Anderson, William G. Williams, Sally Cai, Glen S. Van Arsdell, Tara Karamlou and Brian W. McCrindle

  Circulation. 2017;CIRCULATIONAHA.117.028481, originally published July 7, 2017

  https://doi.org/10.1161/CIRCULATIONAHA.117.028481

  Download PDF
• You have accessRestricted access

  Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children with Heterozygous Familial Hypercholesterolemia: The CHARON Study

  Marjet J. A. M. Braamskamp, Gisle Langslet, Brian W. McCrindle, David M. Cassiman, Gordon A. Francis, Claude Gagne, Daniel Gaudet, Katherine M. Morrison, Albert Wiegman, Traci Turner, Elinor Miller, D. Meeike Kusters, Joel S. Raichlen, Paul D. Martin, Evan A. Stein, John J. P. Kastelein and Barbara A. Hutten

  Circulation. 2017;CIRCULATIONAHA.116.025158, originally published June 7, 2017

  https://doi.org/10.1161/CIRCULATIONAHA.116.025158

  Download PDF
• You have access

  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association

  Brian W. McCrindle, Anne H. Rowley, Jane W. Newburger, Jane C. Burns, Anne F. Bolger, Michael Gewitz, Annette L. Baker, Mary Anne Jackson, Masato Takahashi, Pinak B. Shah, Tohru Kobayashi, Mei-Hwan Wu, Tsutomu T. Saji, Elfriede Pahl On behalf of the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention

  Circulation April 2017, 135 (17) e927-e999; DOI: https://doi.org/10.1161/CIR.0000000000000484

  

  Figure 3.

  By Brian W. McCrindle, Anne H. Rowley, Jane W. Newburger, Jane C. Burns, Anne F. Bolger, Michael Gewitz, Annette L. Baker, Mary Anne Jackson, Masato Takahashi, Pinak B. Shah, Tohru Kobayashi, Mei-Hwan Wu, Tsutomu T. Saji and Elfriede Pahl

  Evaluation of suspected incomplete Kawasaki disease. (1) In the absence of a “gold standard...

  Show More

  Evaluation of suspected incomplete Kawasaki disease. (1) In the absence of a “gold standard” for diagnosis, this algorithm cannot be evidence based but rather represents the informed opinion of the expert committee. Consultation with an expert should be sought any time assistance is needed. (2) Clinical findings of Kawasaki disease are listed in Table 3. Characteristics suggesting that another diagnosis should be considered include exudative conjunctivitis, exudative pharyngitis, ulcerative intraoral lesions, bullous or vesicular rash, generalized adenopathy, or splenomegaly. (3) Infants ≤6 months of age are the most likely to develop prolonged fever without other clinical criteria for Kawasaki disease; these infants are at particularly high risk of developing coronary artery abnormalities. (4) Echocardiography is considered positive for purposes of this algorithm if any of 3 conditions are met: Z score of left anterior descending coronary artery or right coronary artery ≥2.5; coronary artery aneurysm is observed; or ≥3 other suggestive features exist, including decreased left ventricular function, mitral regurgitation, pericardial effusion, or Z scores in left anterior descending coronary artery or right coronary artery of 2 to 2.5. (5) If the echocardiogram is positive, treatment should be given within 10 days of fever onset or after the tenth day of fever in the presence of clinical and laboratory signs (C-reactive protein [CRP], erythrocyte sedimentation rate [ESR]) of ongoing inflammation. (6) Typical peeling begins under the nail beds of fingers and toes. ALT indicates alanine transaminase; and WBC, white blood cells.

  Show Less
• You have access

  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association

  Brian W. McCrindle, Anne H. Rowley, Jane W. Newburger, Jane C. Burns, Anne F. Bolger, Michael Gewitz, Annette L. Baker, Mary Anne Jackson, Masato Takahashi, Pinak B. Shah, Tohru Kobayashi, Mei-Hwan Wu, Tsutomu T. Saji, Elfriede Pahl On behalf of the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention

  Circulation April 2017, 135 (17) e927-e999; DOI: https://doi.org/10.1161/CIR.0000000000000484

  

  Figure 2.

  By Brian W. McCrindle, Anne H. Rowley, Jane W. Newburger, Jane C. Burns, Anne F. Bolger, Michael Gewitz, Annette L. Baker, Mary Anne Jackson, Masato Takahashi, Pinak B. Shah, Tohru Kobayashi, Mei-Hwan Wu, Tsutomu T. Saji and Elfriede Pahl

  Clinical features of classic Kawasaki disease. A, Rash: Maculopapular, dif...

  Show More

  Clinical features of classic Kawasaki disease. A, Rash: Maculopapular, diffuse erythroderma, or erythema multiforme-like. B, Conjunctivitis: Bulbar conjunctival injection without exudate; bilateral. C, Oral changes: Erythema and cracking of lips (cheilitis); strawberry tongue; erythema of oral and pharyngeal mucosa. D and E, Palmar and plantar erythema: Usually accompanied by swelling; resolves with subsequent periungual desquamation in the subacute phase. F, Cervical adenopathy: Usually unilateral, node ≥1.5 cm in diameter. G, Coronary artery aneurysms: Magnetic resonance image of the left ventricular outflow tract showing a giant right coronary artery (RCA) aneurysm with nonocclusive thrombus (yellow arrow) and a giant left main coronary artery (LMCA) aneurysm. Ao indicates aorta; AoV, aortic valve; LV, left ventricle; and RV, right ventricle. H, Peripheral artery aneurysms: Magnetic resonance image showing aneurysms in the axillary and subclavian arteries and the iliac and femoral arteries (yellow arrows). Patient photographs used with permission from the Kawasaki Disease Foundation, Inc.

  Show Less
• You have access

  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association

  Brian W. McCrindle, Anne H. Rowley, Jane W. Newburger, Jane C. Burns, Anne F. Bolger, Michael Gewitz, Annette L. Baker, Mary Anne Jackson, Masato Takahashi, Pinak B. Shah, Tohru Kobayashi, Mei-Hwan Wu, Tsutomu T. Saji, Elfriede Pahl On behalf of the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention

  Circulation April 2017, 135 (17) e927-e999; DOI: https://doi.org/10.1161/CIR.0000000000000484

  View table

  Table 5.

  By Brian W. McCrindle, Anne H. Rowley, Jane W. Newburger, Jane C. Burns, Anne F. Bolger, Michael Gewitz, Annette L. Baker, Mary Anne Jackson, Masato Takahashi, Pinak B. Shah, Tohru Kobayashi, Mei-Hwan Wu, Tsutomu T. Saji and Elfriede Pahl

  Z-Score Methods for Normalizing Coronary Artery Luminal Dimensions From EchocardiographyShow More

  Z-Score Methods for Normalizing Coronary Artery Luminal Dimensions From EchocardiographyShow Less
• You have access

  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association

  Brian W. McCrindle, Anne H. Rowley, Jane W. Newburger, Jane C. Burns, Anne F. Bolger, Michael Gewitz, Annette L. Baker, Mary Anne Jackson, Masato Takahashi, Pinak B. Shah, Tohru Kobayashi, Mei-Hwan Wu, Tsutomu T. Saji, Elfriede Pahl On behalf of the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention

  Circulation April 2017, 135 (17) e927-e999; DOI: https://doi.org/10.1161/CIR.0000000000000484

  View table

  Table 2.

  By Brian W. McCrindle, Anne H. Rowley, Jane W. Newburger, Jane C. Burns, Anne F. Bolger, Michael Gewitz, Annette L. Baker, Mary Anne Jackson, Masato Takahashi, Pinak B. Shah, Tohru Kobayashi, Mei-Hwan Wu, Tsutomu T. Saji and Elfriede Pahl

  Genes Implicated in Susceptibility to KD With Replication in Independent CohortsShow More

  Genes Implicated in Susceptibility to KD With Replication in Independent CohortsShow Less
• You have access

  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association

  Brian W. McCrindle, Anne H. Rowley, Jane W. Newburger, Jane C. Burns, Anne F. Bolger, Michael Gewitz, Annette L. Baker, Mary Anne Jackson, Masato Takahashi, Pinak B. Shah, Tohru Kobayashi, Mei-Hwan Wu, Tsutomu T. Saji, Elfriede Pahl On behalf of the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention

  Circulation April 2017, 135 (17) e927-e999; DOI: https://doi.org/10.1161/CIR.0000000000000484

  View table

  Table 4.

  By Brian W. McCrindle, Anne H. Rowley, Jane W. Newburger, Jane C. Burns, Anne F. Bolger, Michael Gewitz, Annette L. Baker, Mary Anne Jackson, Masato Takahashi, Pinak B. Shah, Tohru Kobayashi, Mei-Hwan Wu, Tsutomu T. Saji and Elfriede Pahl

  Echocardiographic Views of Coronary Arteries in Patients With KDShow More

  Echocardiographic Views of Coronary Arteries in Patients With KDShow Less
• You have access

  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association

  Brian W. McCrindle, Anne H. Rowley, Jane W. Newburger, Jane C. Burns, Anne F. Bolger, Michael Gewitz, Annette L. Baker, Mary Anne Jackson, Masato Takahashi, Pinak B. Shah, Tohru Kobayashi, Mei-Hwan Wu, Tsutomu T. Saji, Elfriede Pahl On behalf of the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention

  Circulation April 2017, 135 (17) e927-e999; DOI: https://doi.org/10.1161/CIR.0000000000000484

  View table

  Table 6.

  By Brian W. McCrindle, Anne H. Rowley, Jane W. Newburger, Jane C. Burns, Anne F. Bolger, Michael Gewitz, Annette L. Baker, Mary Anne Jackson, Masato Takahashi, Pinak B. Shah, Tohru Kobayashi, Mei-Hwan Wu, Tsutomu T. Saji and Elfriede Pahl

  Treatment Options for IVIG-Resistant KD PatientsShow More

  Treatment Options for IVIG-Resistant KD PatientsShow Less
• You have access

  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association

  Brian W. McCrindle, Anne H. Rowley, Jane W. Newburger, Jane C. Burns, Anne F. Bolger, Michael Gewitz, Annette L. Baker, Mary Anne Jackson, Masato Takahashi, Pinak B. Shah, Tohru Kobayashi, Mei-Hwan Wu, Tsutomu T. Saji, Elfriede Pahl On behalf of the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention

  Circulation April 2017, 135 (17) e927-e999; DOI: https://doi.org/10.1161/CIR.0000000000000484

  

  Table 1.

  By Brian W. McCrindle, Anne H. Rowley, Jane W. Newburger, Jane C. Burns, Anne F. Bolger, Michael Gewitz, Annette L. Baker, Mary Anne Jackson, Masato Takahashi, Pinak B. Shah, Tohru Kobayashi, Mei-Hwan Wu, Tsutomu T. Saji and Elfriede Pahl

  Applying Classification of Recommendations and Level of EvidenceShow More

  Applying Classification of Recommendations and Level of EvidenceShow Less
• You have access

  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association

  Brian W. McCrindle, Anne H. Rowley, Jane W. Newburger, Jane C. Burns, Anne F. Bolger, Michael Gewitz, Annette L. Baker, Mary Anne Jackson, Masato Takahashi, Pinak B. Shah, Tohru Kobayashi, Mei-Hwan Wu, Tsutomu T. Saji, Elfriede Pahl On behalf of the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention

  Circulation April 2017, 135 (17) e927-e999; DOI: https://doi.org/10.1161/CIR.0000000000000484

  View table

  Table 3.

  By Brian W. McCrindle, Anne H. Rowley, Jane W. Newburger, Jane C. Burns, Anne F. Bolger, Michael Gewitz, Annette L. Baker, Mary Anne Jackson, Masato Takahashi, Pinak B. Shah, Tohru Kobayashi, Mei-Hwan Wu, Tsutomu T. Saji and Elfriede Pahl

  Diagnosis of Classic KDShow More

  Diagnosis of Classic KDShow Less

Pages